CXCL1 and neoplasm: It is also reported that introduction of CXCR2 in tumor antigen specific CD8+ T cells enhances their infiltration into the tumor that expresses the ligand CXCL1 and thereby reduces tumor growth in a mouse model of colon cancer (131).